Cimpean Anca Maria, Raica Marius, Encica Svetlana, Cornea Remus, Bocan Viorica
Department of Histology, Victor Babeş University of Medicine and Pharmacy, Timişoara, Eftimie Murgu Square nr. 2, Timişoara 300041, Romania.
Ann Anat. 2008;190(3):238-45. doi: 10.1016/j.aanat.2007.05.003. Epub 2008 Feb 1.
Vascular endothelial growth factor A (VEGF-A) is an angiogenic growth factor that is a primary stimulant of the vascularization of solid tumors. In the tumor microenvironment, an upregulation of both VEGF and its receptors occurs, leading to a high concentration of occupied receptors on tumor vascular endothelium. Also, VEGF is involved in the development of the normal vascular network of the thymus. Little is known about VEGF expression in normal and malignant thymic tissue. Our purpose was to study the pattern and localization of VEGF expression in benign conditions of the thymus and thymoma to determine a possible correlation with VEGF receptors VEGFR1, VEGFR2 and microvascular density. All cases were positive for VEGF and VEGFR1, 2 in the epithelial cells, in a cytoplasmic, granular pattern. In the normal thymus, there were positive epithelial cells with subcapsular distribution and Hassall's corpuscle epithelial cells. In acute thymic involution, the positive fields were correlated with dilation and stasis of blood vessels and lymphocyte depletion. Rare positive cells were found in other types of involution; the myasthenic thymus showed an intense and diffuse reaction in lymphoid follicles of the medulla. A strong reaction for VEGF was observed in type B3 thymomas in neoplastic epithelial cells, normal endothelial cells, plasma within the blood vessels and focally in the stroma adjacent to the tumor. Receptors for VEGF were positive in neoplastic epithelial cells and endothelium. We hypothesized that VEGF acts as an immunoregulatory factor in the normal thymus and as proangiogenic and autocrine factor in thymomas.
血管内皮生长因子A(VEGF-A)是一种血管生成生长因子,是实体瘤血管形成的主要刺激因素。在肿瘤微环境中,VEGF及其受体均上调,导致肿瘤血管内皮上有高浓度的被占据受体。此外,VEGF参与胸腺正常血管网络的发育。关于VEGF在正常和恶性胸腺组织中的表达知之甚少。我们的目的是研究VEGF在胸腺良性病变和胸腺瘤中的表达模式及定位,以确定其与VEGF受体VEGFR1、VEGFR2和微血管密度之间可能存在的相关性。所有病例的上皮细胞中VEGF和VEGFR1、2均呈阳性,呈细胞质颗粒状模式。在正常胸腺中,有被膜下分布的阳性上皮细胞和哈氏小体上皮细胞。在急性胸腺退化时,阳性区域与血管扩张和淤血以及淋巴细胞耗竭相关。在其他类型的退化中发现罕见的阳性细胞;重症肌无力胸腺在髓质的淋巴滤泡中显示出强烈而弥漫的反应。在B3型胸腺瘤的肿瘤上皮细胞、正常内皮细胞、血管内血浆以及肿瘤邻近的间质局部区域观察到VEGF的强烈反应。VEGF受体在肿瘤上皮细胞和内皮中呈阳性。我们推测VEGF在正常胸腺中作为免疫调节因子起作用,而在胸腺瘤中作为促血管生成和自分泌因子起作用。